Samantha G Farris1, Michael J Zvolensky2, Norman B Schmidt3. 1. University of Houston, Department of Psychology, 126 Heyne Building, Houston, TX 77024, United States. 2. University of Houston, Department of Psychology, 126 Heyne Building, Houston, TX 77024, United States; The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, 1155 Pressler Street, Houston, TX 77030, United States. Electronic address: mjzvolen@central.uh.edu. 3. Florida State University, Department of Psychology, 1107 W Call St., Tallahassee, FL 32304, United States.
Abstract
BACKGROUND: Negative-reinforcement based cognitive processes have been implicated in the maintenance of cigarette smoking. Given the expectation that smoking will attenuate aversive internal experiences, smokers may be particularly unwilling to experience or remain in contact with smoking-related distress (i.e., experiential avoidance). Yet, there is little known about a cognitive-based process termed smoking-specific experiential avoidance with regard to withdrawal, craving, or negative affect during a quit attempt. METHOD: Data were collected from adult daily smokers (n = 259) participating in a larger smoking cessation trial. Pre- and post-quit experiences of nicotine withdrawal, craving, and negative affect were examined in terms of cognitive-based smoking-specific experimental avoidance, measured by the Avoidance and Inflexibility Scale (AIS). RESULTS: Results indicated that baseline smoking-specific experiential avoidance was associated with greater overall levels of withdrawal, craving, and negative affect at treatment initiation (pre-cessation). Reductions in smoking-specific experiential avoidance from baseline to quit day were associated with increased likelihood of quit day abstinence. Such reductions were also predictive of lower levels of nicotine withdrawal, craving, and negative affect on quit day. Also, less reduction in experiential avoidance was associated with experiencing greater withdrawal in the early phase of quitting. DISCUSSION: The impact of cognitive-based experiential avoidance pertaining to smoking impacts both pre- and post-cessation experiences in terms of negative affect, withdrawal, and smoking cravings and may represent an important treatment target.
BACKGROUND: Negative-reinforcement based cognitive processes have been implicated in the maintenance of cigarette smoking. Given the expectation that smoking will attenuate aversive internal experiences, smokers may be particularly unwilling to experience or remain in contact with smoking-related distress (i.e., experiential avoidance). Yet, there is little known about a cognitive-based process termed smoking-specific experiential avoidance with regard to withdrawal, craving, or negative affect during a quit attempt. METHOD: Data were collected from adult daily smokers (n = 259) participating in a larger smoking cessation trial. Pre- and post-quit experiences of nicotine withdrawal, craving, and negative affect were examined in terms of cognitive-based smoking-specific experimental avoidance, measured by the Avoidance and Inflexibility Scale (AIS). RESULTS: Results indicated that baseline smoking-specific experiential avoidance was associated with greater overall levels of withdrawal, craving, and negative affect at treatment initiation (pre-cessation). Reductions in smoking-specific experiential avoidance from baseline to quit day were associated with increased likelihood of quit day abstinence. Such reductions were also predictive of lower levels of nicotine withdrawal, craving, and negative affect on quit day. Also, less reduction in experiential avoidance was associated with experiencing greater withdrawal in the early phase of quitting. DISCUSSION: The impact of cognitive-based experiential avoidance pertaining to smoking impacts both pre- and post-cessation experiences in terms of negative affect, withdrawal, and smoking cravings and may represent an important treatment target.
Authors: David R Strong; Adam M Leventhal; Daniel P Evatt; Suzanne Haber; Benjamin D Greenberg; David Abrams; Raymond Niaura Journal: J Abnorm Psychol Date: 2011-05-16
Authors: Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt Journal: Subst Abus Date: 2009 Oct-Dec Impact factor: 3.716
Authors: Samantha G Farris; Michael J Zvolensky; Peter J Norton; Julianna Hogan; Angela H Smith; Alexander M Talkovsky; Lorra Garey; Norman B Schmidt Journal: Behav Med Date: 2014-11-14 Impact factor: 3.104
Authors: Lorra Garey; Kara Manning; Danielle E McCarthy; Matthew W Gallagher; Justin M Shepherd; Michael F Orr; Norman B Schmidt; Blaz Rodic; Michael J Zvolensky Journal: Addict Behav Date: 2019-02-21 Impact factor: 3.913
Authors: Lorra Garey; Jafar Bakhshaie; Anka A Vujanovic; Lorraine R Reitzel; Norman B Schmidt; Michael J Zvolensky Journal: Addict Behav Date: 2016-04-02 Impact factor: 3.913
Authors: Lorra Garey; Kara Manning; Charles Jardin; Adam M Leventhal; Matthew Stone; Amanda M Raines; Raina D Pang; Clayton Neighbors; Norman B Schmidt; Michael J Zvolensky Journal: Psychol Assess Date: 2017-08-07
Authors: Tanya R Schlam; Timothy B Baker; Stevens S Smith; Jessica W Cook; Megan E Piper Journal: Nicotine Tob Res Date: 2020-01-27 Impact factor: 4.244
Authors: Emily Y Zeng; Jaimee L Heffner; Wade K Copeland; Kristin E Mull; Jonathan B Bricker Journal: Addict Behav Date: 2016-07-08 Impact factor: 3.913